A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia.
Uy GL, Rettig MP, Stone RM, Konopleva MY, Andreeff M, McFarland K, Shannon W, Fletcher TR, Reineck T, Eades W, Stockerl-Goldstein K, Abboud CN, Jacoby MA, Westervelt P, DiPersio JF.
Uy GL, et al. Among authors: dipersio jf.
Blood Cancer J. 2017 Mar 10;7(3):e542. doi: 10.1038/bcj.2017.21.
Blood Cancer J. 2017.
PMID: 28282031
Free PMC article.
Clinical Trial.
No abstract available.